Propiedad y actividad de insiders de Omeros Corporation (OMER): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $17.34 |
| Capitalización | $1.3B |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $2.2M | $3.4M | $5.9M | $3.1M | $10.5M | $100.8M | $11.0M | $7.1M | $3.4M | $9.7M |
| Inversiones a Corto | $43.1M | $80.4M | $54.6M | $57.7M | $124.5M | $56.5M | $183.9M | $164.7M | $86.7M | $162.1M |
| Cuentas por Cobrar | $12.0M | $17.1M | $22.8M | $35.2M | $3.8M | $82.5M | $242.0M | $6.7M | $36.8M | $36.3M |
| Inventario | $1.1M | $443000 | $52.5M | $1.1M | $1.4M | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $60.3M | $108.4M | $89.9M | $103.7M | $151.3M | $248.0M | $443.2M | $217.9M | $134.1M | $215.7M |
| Inmovilizado Material | $1.2M | $2.1M | $3.8M | $30.9M | $28.1M | $30.0M | $23.3M | $20.6M | $17.6M | $12.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $67.3M | $116.3M | $95.9M | $137.0M | $181.0M | $419.3M | $591.0M | $378.3M | $277.1M | $325.6M |
| Cuentas por Pagar | $2.5M | $6.7M | $6.3M | $5.3M | $4.2M | $13.4M | $6.0M | $7.7M | $5.9M | $4.8M |
| Deuda a Corto | 0 | 0 | 0 | $3.5M | 0 | 0 | $94.4M | $8.6M | $21.0M | $17.1M |
| Pasivos Corrientes | $16.1M | $26.3M | $37.4M | $55.5M | $36.7M | $51.8M | $136.4M | $53.3M | $79.5M | $78.1M |
| Deuda a Largo | $79.5M | $83.3M | $149.0M | $158.2M | $236.3M | $313.5M | $220.9M | $329.7M | $166.6M | $208.5M |
| Pasivos Totales | $104.7M | $119.1M | -$4.2M | $246.0M | $301.8M | $395.5M | $505.3M | $403.3M | $459.7M | $446.9M |
| Reservas | -$469.9M | -$523.4M | $650.1M | -$734.6M | -$872.7M | -$683.1M | -$635.7M | -$753.5M | -$910.3M | -$913.7M |
| Patrimonio Neto | -$37.4M | -$2.8M | $650.1M | -$109.0M | -$120.8M | $23.8M | $85.7M | -$25.0M | -$182.6M | -$121.2M |
| Deuda Total | $80.0M | $84.6M | $151.4M | $194.0M | $268.8M | $347.8M | $342.0M | $361.6M | $207.0M | $239.1M |
| Deuda Neta | $34.7M | $858000 | $91.0M | $133.2M | $133.9M | $190.6M | $147.1M | $189.7M | $116.9M | $67.3M |
| Capital Circulante | $44.2M | $82.1M | $52.5M | $48.3M | $114.5M | $196.2M | $306.9M | $164.6M | $54.6M | $137.6M |
Salud financiera
| Deuda / Patrimonio | -1.63 |
| Ratio corriente | 1.95 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -3.20 |
Rentabilidad
| Rentabilidad sobre capital | -109.40% |
| Rentabilidad sobre capital invertido | -31.14% |
| Rentabilidad sobre activos | 43.52% |
| Margen bruto | 95.77% |
| Margen operativo | -189.53% |
| Margen neto | 324.88% |
Explorar sector: Healthcare · Biotechnology
Más secciones de OMER: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones